Distinct on-treatment HCC risks associated with different decompensation events in HBV patients with cirrhosis.

Yuanyuan KongYameng SunXiaoning WuJialing ZhouHao WangHuiguo DingWen XieGuofeng ChenAnlin MaHongxin PiaoXiaoyuan XuWei JiangBo FengXiaojuan OuHong YouSamuel S LeeJi-Dong Jia

Published in: Hepatology international (2023)

In NA-treated CHB patients with compensated cirrhosis, the risk was higher for HCC than for decompensation; more importantly, different decompensation events conferred distinct HCC risks.

Keyphrases

human health
hepatitis b virus
risk assessment
liver failure
newly diagnosed
replacement therapy